FDA/Industry Workshop September, 19, 2003 Johnson & Johnson Pharmaceutical Research and Development L.L.C. 1 Uses and Abuses of (Adaptive) Randomization:
COMPUTER INTENSIVE AND RE-RANDOMIZATION TESTS IN CLINICAL TRIALS Thomas Hammerstrom, Ph.D. USFDA, Division of Biometrics The opinions expressed are those.
Fixing the leaks in the pipeline from public genomics data to the clinic
Girls’ scholarship program. Often small/no impacts on actual learning in education research ◦ Inputs (textbooks, flipcharts) little impact on learning.
SESSION 2 Mediation and moderation of treatment effects Andrew Pickles Methods of explanatory analysis for psychological treatment trials workshop Methodology.
Grandparenting and health in Europe: a longitudinal analysis Di Gessa G, Glaser K and Tinker A Institute of Gerontology, Department of Social Science,
1 Variable Selection for Tailoring Treatment L. Gunter, J. Zhu & S.A. Murphy ASA, Nov 11, 2008.
Variable Selection for Optimal Decision Making Susan Murphy & Lacey Gunter University of Michigan Statistics Department Artificial Intelligence Seminar.
Kenneth W. Mahaffey, Zhen Huang, Pierluigi Tricoci, Frans Van de Werf, Harvey D. White, Paul W. Armstrong, Claes Held, Sergio Leonardi, Philip E. Aylward,
Catherine Kober Margaret Johnson Martin Fisher Caroline Sabin On behalf of UK-CHIC BHIVA/BASHH Manchester 2010 Non-uptake of HAART among patients with.
Grandparenting and health in Europe: a longitudinal analysis
RESOLUTE US One-Year Clinical Outcomes from the Pivotal Multicenter RESOLUTE US Study Objective To evaluate the clinical effectiveness of the Resolute.
